Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase-neo cassette located between the murine beta-major and beta-minor globin genes.
暂无分享,去创建一个
T. Ley | G. K. Ackers | J. Holt | R. Behl | Z. Lu | R. Kaufman
[1] S. Bentley,et al. Gene correction in hematopoietic progenitor cells by homologous recombination. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] Michel Sadelain,et al. Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin , 2000, Nature.
[3] A. Nienhuis,et al. Gene therapy for the hemoglobin disorders: past, present, and future. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] T. Ley,et al. Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. , 1999, Blood.
[5] A. Porter,et al. Gene targeting is enhanced in human cells overexpressing hRAD51 , 1999, Gene Therapy.
[6] S. Walker,et al. Quantitative RT-PCR : Pitfalls and Potential , 1999 .
[7] T. Ley,et al. The 5' flanking region of the human granzyme H gene directs expression to T/natural killer cell progenitors and lymphokine-activated killer cells in transgenic mice. , 1999, Blood.
[8] Y. Kan,et al. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Groudine,et al. The Locus Control Region Is Necessary for Gene Expression in the Human β-Globin Locus but Not the Maintenance of an Open Chromatin Structure in Erythroid Cells , 1998, Molecular and Cellular Biology.
[10] B. Sullenger,et al. Ribozyme-Mediated Repair of Sickle β-Globin mRNAs in Erythrocyte Precursors , 1998 .
[11] T. Ley,et al. Stochastic, stage-specific mechanisms account for the variegation of a human globin transgene. , 1998, Nucleic acids research.
[12] S. Rivella,et al. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. , 1998, Seminars in hematology.
[13] D. Russell,et al. Human gene targeting by viral vectors , 1998, Nature Genetics.
[14] R. Kingston,et al. Disruption of downstream chromatin directed by a transcriptional activator. , 1997, Genes & development.
[15] E. Rubin,et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. , 1997, Science.
[16] T. Townes,et al. Knockout-transgenic mouse model of sickle cell disease. , 1997, Science.
[17] S. Orkin,et al. A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Gore,et al. Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease. , 1996, The Journal of clinical investigation.
[19] T. Ley,et al. Long-range disruption of gene expression by a selectable marker cassette. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Rice,et al. Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide , 1996, Science.
[21] T. Ley,et al. Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3 , 1996, Molecular and cellular biology.
[22] B. Wold,et al. Know Your Neighbors: Three Phenotypes in Null Mutants of the Myogenic bHLH Gene MRF4 , 1996, Cell.
[23] T. Ley,et al. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. , 1995, Genes & development.
[24] F. Grosveld,et al. Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Baron,et al. The Molecular Basis of Blood Diseases , 1994 .
[26] T. Townes,et al. Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice. , 1994, Nucleic acids research.
[27] S. Orkin,et al. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. , 1993, Blood.
[28] M. Groudine,et al. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Shehee,et al. Lethal thalassemia after insertional disruption of the mouse major adult beta-globin gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] I. Plavec,et al. A human beta-globin gene fused to the human beta-globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells. , 1993, Blood.
[31] R. Nagel,et al. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Nagel,et al. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Doyle,et al. Regulation of oxygen affinity by quaternary enhancement: Does hemoglobin ypsilanti represent an allosteric intermediate? , 1992, Proteins.
[34] D. Valerio,et al. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] W. C. Forrester,et al. Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region. , 1992, Genes & development.
[36] H. S. Kim,et al. Correction of a human beta S-globin gene by gene targeting. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. C. Forrester,et al. High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] L. Skow,et al. A mouse model for β-thalassemia , 1983, Cell.
[39] L. Skow,et al. A Mouse Model for b-Thalassemia , 1982 .
[40] B. Alter,et al. Globin Chain Electrophoresis: a New Approach to the Determination of the Gγ/Aγ Ratio in Fetal Haemoglobin and to Studies of Globin Synthesis , 1980 .
[41] Arthur W. Nienhuis,et al. Hemoglobin switching , 1978, Cell.
[42] S. Gill,et al. Membrane-covered thin-layer optical cell for gas-reaction studies of hemoglobin. , 1978, Analytical biochemistry.
[43] R. Nagel,et al. High expression of human pBs and a-globins in transgenic mice: Hemoglobin composition and hematological consequences , 2022 .
[44] R. Nagel,et al. High expression of human 8s- and a-globins in transgenic mice: Erythrocyte abnormalities, organ damage, and the effect of hypoxia , 2022 .